239 related articles for article (PubMed ID: 23640395)
1. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice.
Chandra D; Jahangir A; Quispe-Tintaya W; Einstein MH; Gravekamp C
Br J Cancer; 2013 Jun; 108(11):2281-90. PubMed ID: 23640395
[TBL] [Abstract][Full Text] [Related]
2. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
[TBL] [Abstract][Full Text] [Related]
3. Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy.
Singh M; Quispe-Tintaya W; Chandra D; Jahangir A; Venkataswamy MM; Ng TW; Sharma-Kharkwal S; Carreño LJ; Porcelli SA; Gravekamp C
Br J Cancer; 2014 Nov; 111(10):1945-54. PubMed ID: 25314062
[TBL] [Abstract][Full Text] [Related]
4. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
5. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer.
Chandra D; Quispe-Tintaya W; Jahangir A; Asafu-Adjei D; Ramos I; Sintim HO; Zhou J; Hayakawa Y; Karaolis DK; Gravekamp C
Cancer Immunol Res; 2014 Sep; 2(9):901-10. PubMed ID: 24913717
[TBL] [Abstract][Full Text] [Related]
6. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.
Veltman JD; Lambers ME; van Nimwegen M; Hendriks RW; Hoogsteden HC; Aerts JG; Hegmans JP
BMC Cancer; 2010 Aug; 10():464. PubMed ID: 20804550
[TBL] [Abstract][Full Text] [Related]
7. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.
Kim SH; Castro F; Gonzalez D; Maciag PC; Paterson Y; Gravekamp C
Br J Cancer; 2008 Sep; 99(5):741-9. PubMed ID: 18728665
[TBL] [Abstract][Full Text] [Related]
8. Activation of immature hepatic NK cells as immunotherapy for liver metastatic disease.
Bahjat KS; Prell RA; Allen HE; Liu W; Lemmens EE; Leong ML; Portnoy DA; Dubensky TW; Brockstedt DG; Giedlin MA
J Immunol; 2007 Dec; 179(11):7376-84. PubMed ID: 18025181
[TBL] [Abstract][Full Text] [Related]
9. Expression of the p60 autolysin enhances NK cell activation and is required for listeria monocytogenes expansion in IFN-gamma-responsive mice.
Humann J; Bjordahl R; Andreasen K; Lenz LL
J Immunol; 2007 Feb; 178(4):2407-14. PubMed ID: 17277147
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.
Alizadeh D; Trad M; Hanke NT; Larmonier CB; Janikashvili N; Bonnotte B; Katsanis E; Larmonier N
Cancer Res; 2014 Jan; 74(1):104-18. PubMed ID: 24197130
[TBL] [Abstract][Full Text] [Related]
12. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
Guo S; Smeltz RB; Nanajian A; Heller R
Front Immunol; 2020; 11():614667. PubMed ID: 33628206
[TBL] [Abstract][Full Text] [Related]
13. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.
Wallecha A; Singh R; Malinina I
J Immunother; 2013; 36(9):468-76. PubMed ID: 24145358
[TBL] [Abstract][Full Text] [Related]
14. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms.
Jahangir A; Chandra D; Quispe-Tintaya W; Singh M; Selvanesan BC; Gravekamp C
Oncoimmunology; 2017; 6(9):e1342025. PubMed ID: 28932647
[TBL] [Abstract][Full Text] [Related]
16. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
Bunt SK; Yang L; Sinha P; Clements VK; Leips J; Ostrand-Rosenberg S
Cancer Res; 2007 Oct; 67(20):10019-26. PubMed ID: 17942936
[TBL] [Abstract][Full Text] [Related]
17. Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer.
Gibson JT; Orlandella RM; Turbitt WJ; Behring M; Manne U; Sorge RE; Norian LA
Front Immunol; 2020; 11():590794. PubMed ID: 33123173
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY; Zebala JA; Clavijo PE; Allen C
Clin Cancer Res; 2020 Mar; 26(6):1420-1431. PubMed ID: 31848188
[TBL] [Abstract][Full Text] [Related]
19. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
